Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma.

Authors
Type
Published Article
Journal
Journal of Clinical Oncology
1527-7755
Publisher
American Society of Clinical Oncology
Publication Date
Volume
30
Issue
18
Pages
2183–2189
Identifiers
DOI: 10.1200/JCO.2011.38.0410
PMID: 22454421
Source
Medline

Abstract

Statistics

Seen <100 times